Psyma has many years of expertise in ad hoc qualitative healthcare research in China. This led to a deep understanding of traditional Chinese medicine (TCM) paired with solid experience in prescription drugs. Our expert staff has critically important knowledge of the Chinese healthcare system. In addition, we constantly keep up-to-date with the latest changes in the regulatory environment. Psyma combines best-in-class methodologies with cultural insights for actionable results.
Psyma China is flexible enough to offer a large spectrum of services and methodologies ranging from in-depth interviews with doctors to ethnographic patient research. Yet, we are large enough to provide access to medical professionals and patients from all types of Chinese hospitals. Our main offices in Shanghai and Beijing serve as a hub from which we cover the entire geographical area of China. Psyma China is a member of ESOMAR and EphMRA.
State-of-the-Art Research Facilities